GlassScriptPhysician profile
Terence F Duffy
NPI 1740232362
$3,587.34
in general payments reported to CMS, 2019-2025
38 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $389 · 2021: $515 · 2022: $540 · 2023: $628 · 2024: $436 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $607.26 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $481.40 | 2019-2024 | Belbuca, Xtampza |
| Tersera Therapeutics LLC | $340.20 | 2019-2025 | Prialt |
| Boston Scientific Corporation | $218.90 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Daiichi Sankyo INC. | $186.92 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.34 | 2019-2025 | Relistor |
| Vertos Medical, INC. | $162.44 | 2021-2024 | Mild Device Kit |
| Medtronic, INC. | $139.22 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $131.49 | 2019-2021 | |
| Redhill Biopharma INC. | $109.69 | 2020-2021 | |
| Biotronik Nro, INC. | $102.91 | 2025 | Prospera |
| Medtronic USA, INC. | $88.79 | 2019-2020 | |
| Abbvie INC. | $85.07 | 2021-2023 | Qulipta, Ubrelvy |
| Pfizer INC. | $75.78 | 2023-2025 | |
| Pacira Therapeutics, INC. | $67.84 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $58.08 | 2025 | Movantik |
| Electronic Waveform Lab, INC. | $52.57 | 2020-2022 | |
| Lilly USA, LLC | $51.34 | 2019-2020 | |
| Grt US Holding, INC. | $49.58 | 2022 | |
| Impel Pharmaceuticals LLC | $36.96 | 2025 | Trudhesa |
| Globus Medical, INC. | $34.33 | 2025 | Senza |
| Protega Pharmaceutials INC | $32.98 | 2022-2023 | Roxybond |
| Biohaven Pharmaceuticals, INC. | $32.01 | 2021 | |
| Amgen INC. | $29.55 | 2021 | |
| Ibsa Pharma INC. | $29.17 | 2021 | |
| Nevro Corp. | $28.41 | 2019-2021 | |
| Averitas Pharma INC. | $18.75 | 2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $17.98 | 2025 | |
| Si-Bone, INC. | $17.75 | 2024 | |
| Novo Nordisk INC | $16.27 | 2023 | |
| Appliedvr INC | $15.86 | 2025 | Relievrx |
| Spinal Simplicity, LLC | $15.46 | 2025 | Ha Minuteman G3-R |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2023 | Seglentis |
| Spr Therapeutics, INC | $13.93 | 2020 | |
| Forte Bio-Pharma LLC | $12.40 | 2021 | |
| Horizon Therapeutics Plc | $12.34 | 2021 | |
| Biodelivery Sciences International, INC. | $12.17 | 2020 | |
| Foundation Fusion Solutions, LLC | $8.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terence Duffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.